Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Carcinoma, Squamous Cell × 130-nm albumin-bound paclitaxel × Clear all

Phase

Phase 2 3 Phase 1 2 Phase 4 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thymoma 1 Lung Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Large Cell 1 Carcinoma 1 Advanced Gastric Cancer 1 Adenocarcinoma Pancreas 1 Adenocarcinoma 1

Interventions

nedaplatin 1 Fibrin Tissue Adhesive 1 Docetaxel 1 Cisplatin 1 Carboplatin 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02151149 2018-09-24

ABOUND 70+

Celgene

Phase 4 Completed

143 enrolled 25 charts

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Carcinoma, Large Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡